The company will focus on creating small molecule therapeutics that enhance the natural function of proteasomes. Credit: Gorodenkoff/Shutterstock. Booster Therapeutics has announced its inception, backed
Lilly will gain worldwide rights for the development and commercialisation of DACRA molecules to treat obesity. Credit: New Africa/Shutterstock. Nordic Bioscience subsidiary KeyBioscience has announced
Merck’s new €290m biosafety testing facility in Rockville features advanced testing capabilities. Credit: Merck/Business Wire. Germany-based Merck KGaA has announced the launch of a new
The company’s single-cell-based discovery engine can detect the specific pathogenic cells that cause disease, and their surface markers. Credit: PeopleImages.com – Yuri A/Shutterstock. Arda Therapeutics
Boehringer Ingelheim focuses on targeting the proteins involved in this process as a promising strategy for developing new cancer treatments. Credit: Tada Images/Shutterstock. Boehringer Ingelheim
The company had sought approval for dasiglucagon for the treatment and prevention of hypoglycaemia in infants with congenital hyperinsulinism. Credit: Gorodenkoff/Shutterstock. The US Food and
City Therapeutics is developing an siRNA-engineering platform to design, enhance, and optimise RNAi-based medicines. Credit: PeopleImages.com – Yuri A/Shutterstock. City Therapeutics has announced its launch,
The prescribed dosage of Elafibranor is one tablet a day, taken consistently at the same time. Credit: PeopleImages.com – Yuri A/Shutterstock. Ipsen has received the
Bayer will oversee the programme’s progression through further preclinical development and potential commercialisation. Credit: Lightspring/Shutterstock. Bayer has entered a strategic collaboration with MOMA Therapeutics to
The long-acting injectable PrEP option is being rolled out at a record pace in sub-Saharan Africa and lower-income countries. Credit: elenavolf/Shutterstock. ViiV Healthcare has announced